Andrew Szehsun Chiang

Suggest Changes
Learn More
BACKGROUND AND PURPOSE Stereotactic ablative radiotherapy (SABR) has become standard for inoperable early-stage non-small cell lung cancer (NSCLC). However, there is no randomized evidence(More)
  • 1